- Advertisement -

Related

Alcur Grow(s)

- Advertisement -

Stockholm (HedgeNordic) – Swedish asset manager Alcur Fonder is expanding its fund range with the upcoming launch of a long-only equity fund called Alcur Grow. Expected to launch at the beginning of next year, the fund will maintain a portfolio that contains between 25 to 30 Nordic small- and medium-sized public companies.

Alcur Grow is regulated as a Swedish alternative investment fund but will not engage in short selling. The long-only equity fund can hold up to 30 percent of its portfolio in cash and can make use of leverage. The entire investment team at Alcur Fonder will manage the soon-to-be-launched fund, with Mikael Holm-Lorsell being the responsible manager. Before joining Alcur Fonder as a portfolio manager in January 2019, Holm worked as an equity analyst at Danske Markets, Erik Penser and Swedbank Markets for more than ten years.

Alcur Grow’s investment strategy will rely on the same “Alcur Manual” investment process used to run the asset manager’s two hedge funds, Alcur and Alcur Select. The fund seeks to own its underlying investments for a long time, aiming to build a concentrated portfolio of the Nordic region’s leading companies of the future. “The fund will probably tend to co-move more with the market than our other funds,” writes Alcur Fonder in an announcement, “but at the same time, the risks in the fund are strongly associated with the development of individual companies.”

Alcur Fonder currently manages two hedge funds with different risk-reward profiles. Alcur Select is a long-biased small-cap-focused equity hedge fund managed by a team with Wilhelm Gruvberg in charge. The fund advanced 48.3 percent year-to-date through mid-November and recently received the top honors in the “European Equity: Over $100m” category at the 2020 HFM European Emerging Manager Awards. Alcur Fonder’s older fund, Alcur, is a lower-risk long/short absolute return fund that delivered an annualized return of 5.4 percent since its launch at the beginning of 2007 and gained 13.5 percent year-to-date through mid-November.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Beyond Shipping: Gersemi Develops Crypto Strategy

With years of experience as a sell-side analyst and later as a fund manager, Joakim Hannisdahl has developed deep expertise in shipping sectors and...

Folketrygdfondet on Nordic High Yield: More Global, but Is It More Resilient?

While Norway’s global sovereign wealth giant, the Government Pension Fund Global, widely known as the Oil Fund, invests trillions across international markets, its lesser-known...

Danske Bank AM Claims Top Honor as Nykredit Wins Fixed Income

Nordic managers were strongly represented at this year’s EuroHedge Awards, sweeping the nominations in the Fixed Income category. With the entire “Fixed Income” field...

AP3 Hires Lynx’s Mattias Sundbom as Head of Portfolio Strategy

After spending the past decade at some of Sweden’s largest systematic asset managers, most recently at Lynx Asset Management, Mattias Sundbom has now moved...

Colosseum’s Rollercoaster Start Gives Way to Strong Rebound

Early investors in the freshly launched Colosseum Global Alpha have experienced a rollercoaster ride in recent months, though the latest stretch has been largely...

Nordic CTAs Thrive in February’s Volatile Macro Landscape

February proved to be another favorable month for Nordic CTA managers, leaving CTAs as the best-performing sub-strategy in the Nordic Hedge Index so far...

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -